<DOC>
	<DOCNO>NCT00814957</DOCNO>
	<brief_summary>The purpose study investigate relationship plasma concentration study drug amount study drug bound D3 receptor brain dose new compound GSK618334 .</brief_summary>
	<brief_title>An Open Label Positron Emission Tomography ( PET ) Study GSK618334 Healthy Male Subjects Using 11C-PHNO PET Ligand</brief_title>
	<detailed_description>This imaging study open label , non-randomised PET receptor occupancy study use healthy male volunteer . The time course degree D3 receptor occupancy ( RO ) single dos GSK618334 determine use 11C-PHNO PET ligand label dopamine receptor . The PK/PD relationship plasma concentration GSK618334 D3 RO describe . Potential relationship D3 RO functional magnetic resonance imaging ( fMRI ) endpoint assess exploratory aim .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Naxagolide</mesh_term>
	<criteria>healthy , male subject age 30 55 old inclusive . normal body weight . normal ECG vital sign . agree use acceptable contraceptive method require . capable give write informed consent . smoker use nicotinecontaining product . certain medical condition include heart disease , neurological disease , gastrointestinal disease , kidney liver dysfunction abnormal laboratory test . certain psychiatric condition use certain psychoactive drug . positive blood alcohol urine drug test . alcohol intake 14 drink per week . participation another drug trial within 30 day study involve significant radiation exposure . donation 450 mL blood within 56 day . family history cancer ( one firstdegree relative diagnose age 55 year old ) . cardiac pacemaker electronic device . suffers claustrophobia feel unable lie still back PET camera .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>positron emission tomography</keyword>
	<keyword>addiction</keyword>
</DOC>